"Everywhere I go, I'm asked if I think the universities stifle writers. My opinion is that they don't stifle enough of them."
— Flannery O'Connor








Doctors Study Residual Disease in Kids with Leukemia


EVANSTON, Ill., Sept. 14, 2000 — The Leukemia Research Foundation (LRF) recently announced major grant award recipients at top international laboratories doing research into the detection and management of minimal residual disease (MRD) in pediatric leukemia patients.

MRD occurs when small numbers of leukemic cells remain hidden in a child's body after the child appears to go into remission. Eventually the residual cells grow to large numbers and the child's leukemia relapses.

The LRF is dedicated to the eradication of leukemia and related blood cancers. Its growing research program annually supports young investigators and post-doctoral fellows conducting research in these areas on a worldwide basis, in addition to the MRD senior scientist grants.

MRD occurs when small numbers of leukemic cells remain hidden in a child's body after the child appears to go into remission. Eventually the residual cells grow to large numbers and the child's leukemia relapses.

Two senior scientists, Dario Campana, M.D., Ph.D., St. Jude Children's Research Hospital in Memphis, Tenn., and Martin Schrappe, M.D., Medical School of Hannover, Germany, have each been awarded two-year, $200,000 grants for their innovative research in this area.

Dr. Campana's research is utilizing state-of-the-art genetic technology to create a new, more effective tool for detecting extremely small quantities of MRD. Dr. Schrappe's research is working towards more refined, standardized methods for monitoring MRD and selecting appropriate treatments for patients identified to be at high-risk for relapse. The results of these physicians' work will improve the prognosis and treatment for pediatric leukemia patients.

The Evanston, Ill.-based Leukemia Research Foundation has been funding research into the causes and cures of leukemia and related blood cancers for more than 50 years, issuing grants totaling $12 million to more than 400 scientists and physicians. Begun 54 years ago by a family who lost a child to leukemia, today the nationally recognized organization boasts 1,000 members among 20 active chapters.

The LRF mission is to conquer leukemia, lymphoma, and myelodysplastic syndromes by funding research into their causes and cures, and to enrich the quality of life of those touched by these diseases. To learn more about the research funded by this organization and the services available to patients and their families, or to download a research grant application, visit the Leukemia Research Foundation web site or call (847) 424-0600.

Source: The Leukemia Research Foundation




Give me a holler

CMLSupport Home Page

This site was last updated on Sept. 16, 2000

Copyright © 2000 Jennifer M. Gangloff.
These contents may not be reproduced in whole or in part without the express written permission of the author, or she will beat you up and stuff.